Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer

NCT01108055 is registered in ClinicalTrials.gov with Sandy Srinivas as lead sponsor.

NCT NCT01108055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01108055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer
Lead sponsor
Sandy Srinivas
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2010
Completion date
July 31, 2015
Enrollment
43 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bladder (urothelial, transitional cell) cancer, bladder (urothelial, transitional cell) cancer metastatic or unresectable, bladder (urothelial, transitional cell) cancer resectable (pre-cystectomy), bladder (urothelial, transitional cell) cancer superficial (non-invasive), bladder cancer